[Prolonged corticotherapy for psoriasis in a young child. Arrest of statural growth. Erythroderma].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001623:Betamethasone / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003348:Cortisone / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D004392:Dwarfism / Q000139:chemically induced; D006128:Growth / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone; D007223:Infant; D008297:Male
D000893:Anti-Inflammatory Agents; D001623:Betamethasone; D003348:Cortisone; D006854:Hydrocortisone
Corticothérapie prolongée pour psoriasis chez un jeune enfant. Arrêt de développement statural. Erythrodermie.